TNDM
Tandem Diabetes Care, Inc.
Price Chart
Latest Quote
$17.08
+0.79 (+4.85%)
Current Price
| Previous Close | $16.29 |
| Open | $16.25 |
| Day High | $17.09 |
| Day Low | $15.91 |
| Volume | 2,053,115 |
Stock Information
| Shares Outstanding | 68.53M |
| Total Debt | $734.73M |
| Cash Equivalents | $570.26M |
| Revenue | $1.03B |
| Net Income | $-94.55M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $1.17B |
| EPS (TTM) | $-1.37 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.33B |
| Sales | $1.03B |
| Income | $-94.55M |
| Book/sh | $1.93 |
| Cash/sh | $8.32 |
| Employees | 2K |
Financial Ratios
| Quick Ratio | 2.87 |
| Current Ratio | 3.58 |
| Debt/Eq | 554.92 |
Returns & Margins
| ROA | -3.68% |
| ROE | -65.73% |
| Gross Margin | 54.93% |
| Operating Margin | -7.05% |
| Profit Margin | -9.20% |
Ownership
| Insider Ownership | 0.97% |
| Institutional Ownership | 117.83% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 150.13 |
| P/S | 1.14 |
| P/B | 8.84 |
Analyst Data
| Recommendation | buy |
| Target Price | $29.08 |
Technical Indicators
| SMA20 | $15.51 |
| SMA50 | $15.95 |
| SMA200 | $18.82 |
| RSI | 56.48 |
| ATR | 0.9384 |
| Shares Float | 62.92M |
| Short Float | 25.01% |
| Short Ratio | 5.05 |
| Volatility | 1.58 |
| Rel Volume | 1.10 |
Performance History
| Week | +10.84% |
| Month | +2.34% |
| Quarter | -14.98% |
| 6 Months | -18.16% |
| YTD | -20.74% |
| Year | +8.44% |
| 3 Years | -41.98% |
| 5 Years | -82.44% |
| 10 Years | -78.46% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $17.08 | 2,100,400 |
| 2026-07-16 | $16.29 | 1,982,800 |
| 2026-07-15 | $15.28 | 1,381,900 |
| 2026-07-14 | $15.54 | 1,882,900 |
| 2026-07-13 | $16.25 | 1,897,000 |
| 2026-07-10 | $15.41 | 1,321,200 |
| 2026-07-09 | $15.37 | 1,398,300 |
| 2026-07-08 | $15.16 | 1,871,100 |
| 2026-07-07 | $15.43 | 1,207,500 |
| 2026-07-06 | $15.42 | 1,322,400 |
| 2026-07-02 | $15.32 | 1,627,600 |
| 2026-07-01 | $15.75 | 1,312,700 |
| 2026-06-30 | $15.09 | 1,145,900 |
| 2026-06-29 | $15.83 | 1,467,200 |
| 2026-06-26 | $16.24 | 3,369,100 |
| 2026-06-25 | $15.76 | 2,304,900 |
| 2026-06-24 | $15.02 | 2,206,500 |
| 2026-06-23 | $14.41 | 3,498,100 |
| 2026-06-22 | $14.34 | 2,451,800 |
| 2026-06-18 | $15.30 | 2,537,800 |
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
đ° Latest News
1 Unprofitable Stock with Exciting Potential and 2 Facing Challenges
StockStory âĸ 2026-07-17T13:05:46Z
Unpacking Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks
StockStory âĸ 2026-07-16T19:05:22Z
Does Libre 3 Plus Integration Expand Tandemâs Interoperability Edge And Bull Case For TNDM?
Simply Wall St. âĸ 2026-07-12T01:07:12Z
Is Tandem Diabetes Care (TNDM) Undervalued Following Its Abbott Libre 3 Plus Expansion?
Simply Wall St. âĸ 2026-07-11T09:09:21Z
DXCM Grew. The Stock Did Not. Someone Is Wrong
Trefis âĸ 2026-07-10T12:08:37Z
1 of Wall Streetâs Favorite Stocks with Exciting Potential and 2 We Turn Down
StockStory âĸ 2026-07-09T13:09:00Z
Is Abbott Laboratories (ABT) Stock Still a Healthcare Growth Opportunity After Analyst Target Cut?
Insider Monkey âĸ 2026-07-08T14:49:53Z
Does TNDM Stock Still Deserve a Place in Your Portfolio?
Zacks âĸ 2026-07-07T13:56:00Z
Is the Market Underestimating Tandem Diabetes Care, Inc. (TNDM)âs Transition Risks?
Insider Monkey âĸ 2026-07-07T05:53:57Z
Why Tandem Diabetes (TNDM) Shares Are Sliding Today
StockStory âĸ 2026-06-30T23:39:01Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $468,722,000 | $450,629,000 | $380,028,000 | $388,231,000 |
| Cost Of Revenue | $468,722,000 | $450,629,000 | $380,028,000 | $388,231,000 |
| Total Revenue | $1,014,736,000 | $940,203,000 | $747,718,000 | $801,217,000 |
| Operating Revenue | $1,014,736,000 | $940,203,000 | $747,718,000 | $801,217,000 |
| Expenses | ||||
| Interest Expense | $6,047,000 | $5,509,000 | $8,079,000 | $4,313,000 |
| Total Expenses | $1,182,042,000 | $1,039,330,000 | $980,948,000 | $894,065,000 |
| Other Income Expense | $-34,145,000 | $-3,321,000 | $-78,750,000 | $147,000 |
| Net Non Operating Interest Income Expense | $1,179,000 | $10,578,000 | $12,976,000 | $-152,000 |
| Total Other Finance Cost | $1,860,000 | $1,906,000 | $1,803,000 | $1,896,000 |
| Interest Expense Non Operating | $6,047,000 | $5,509,000 | $8,079,000 | $4,313,000 |
| Operating Expense | $713,320,000 | $588,701,000 | $600,920,000 | $505,834,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-204,710,000 | $-96,025,000 | $-222,611,000 | $-94,594,000 |
| Net Interest Income | $1,179,000 | $10,578,000 | $12,976,000 | $-152,000 |
| Interest Income | $9,086,000 | $17,993,000 | $22,858,000 | $6,057,000 |
| Normalized Income | $-188,948,710 | $-95,023,280 | $-222,611,000 | $-94,710,130 |
| Net Income From Continuing And Discontinued Operation | $-204,710,000 | $-96,025,000 | $-222,611,000 | $-94,594,000 |
| Total Operating Income As Reported | $-187,257,000 | $-99,127,000 | $-233,230,000 | $-92,848,000 |
| Net Income Common Stockholders | $-204,710,000 | $-96,025,000 | $-222,611,000 | $-94,594,000 |
| Net Income | $-204,710,000 | $-96,025,000 | $-222,611,000 | $-94,594,000 |
| Net Income Including Noncontrolling Interests | $-204,710,000 | $-96,025,000 | $-222,611,000 | $-94,594,000 |
| Net Income Continuous Operations | $-204,710,000 | $-96,025,000 | $-222,611,000 | $-94,594,000 |
| Pretax Income | $-200,272,000 | $-91,870,000 | $-220,254,000 | $-92,852,000 |
| Special Income Charges | $-19,951,000 | $-1,268,000 | $0 | $0 |
| Earnings From Equity Interest | $-14,194,000 | $-2,053,000 | $0 | $0 |
| Interest Income Non Operating | $9,086,000 | $17,993,000 | $22,858,000 | $6,057,000 |
| Operating Income | $-167,306,000 | $-99,127,000 | $-233,230,000 | $-92,848,000 |
| Gross Profit | $546,014,000 | $489,574,000 | $367,690,000 | $412,986,000 |
| Per Share | ||||
| Diluted EPS | $-3.04 | $-1.47 | $-3.43 | $-1.47 |
| Basic EPS | $-3.04 | $-1.47 | $-3.43 | $-1.47 |
| Other | ||||
| Tax Effect Of Unusual Items | $-4,189,710 | $-266,280 | $0 | $30,870 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-156,608,000 | $-68,486,000 | $-196,460,000 | $-74,356,000 |
| Total Unusual Items | $-19,951,000 | $-1,268,000 | $0 | $147,000 |
| Total Unusual Items Excluding Goodwill | $-19,951,000 | $-1,268,000 | $0 | $147,000 |
| Reconciled Depreciation | $17,666,000 | $16,607,000 | $15,715,000 | $14,330,000 |
| EBITDA (Bullshit earnings) | $-176,559,000 | $-69,754,000 | $-196,460,000 | $-74,209,000 |
| EBIT | $-194,225,000 | $-86,361,000 | $-212,175,000 | $-88,539,000 |
| Diluted Average Shares | $67,285,000 | $65,451,000 | $64,969,000 | $64,146,000 |
| Basic Average Shares | $67,285,000 | $65,451,000 | $64,969,000 | $64,146,000 |
| Diluted NI Availto Com Stockholders | $-204,710,000 | $-96,025,000 | $-222,611,000 | $-94,594,000 |
| Tax Provision | $4,438,000 | $4,155,000 | $2,357,000 | $1,742,000 |
| Other Special Charges | $19,951,000 | $1,268,000 | $78,750,000 | $31,039,000 |
| Research And Development | $268,331,000 | $198,877,000 | $248,417,000 | $170,153,000 |
| Selling General And Administration | $444,989,000 | $389,824,000 | $352,503,000 | $335,681,000 |
| Gain On Sale Of Security | - | - | - | $147,000 |
Fetched: 2026-07-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $143,450,000 | $262,173,000 | $310,856,000 | $435,320,000 |
| Total Assets | $881,112,000 | $967,658,000 | $952,658,000 | $1,052,785,000 |
| Total Non Current Assets | $262,969,000 | $243,167,000 | $204,669,000 | $202,809,000 |
| Other Non Current Assets | $11,146,000 | $4,241,000 | $37,560,000 | $19,004,000 |
| Goodwill And Other Intangible Assets | $11,720,000 | $925,000 | $2,776,000 | $4,627,000 |
| Other Intangible Assets | $11,720,000 | $925,000 | $2,776,000 | $4,627,000 |
| Current Assets | $618,143,000 | $724,491,000 | $747,989,000 | $849,976,000 |
| Other Current Assets | $31,217,000 | $21,965,000 | $16,585,000 | $7,241,000 |
| Inventory | $128,769,000 | $149,612,000 | $157,937,000 | $111,117,000 |
| Receivables | $165,491,000 | $114,585,000 | $105,555,000 | $114,717,000 |
| Accounts Receivable | $165,491,000 | $114,585,000 | $105,555,000 | $114,717,000 |
| Allowance For Doubtful Accounts Receivable | $-8,393,000 | $-7,251,000 | $-4,898,000 | $-4,327,000 |
| Gross Accounts Receivable | $173,884,000 | $121,836,000 | $110,453,000 | $119,044,000 |
| Cash Cash Equivalents And Short Term Investments | $292,666,000 | $438,329,000 | $467,912,000 | $616,901,000 |
| Cash And Cash Equivalents | $90,634,000 | $69,234,000 | $58,868,000 | $172,517,000 |
| Prepaid Assets | - | - | - | - |
| Cash Equivalents | - | - | - | - |
| Cash Financial | - | - | - | - |
| Debt | ||||
| Net Debt | $219,402,000 | $279,702,000 | $226,167,000 | $110,715,000 |
| Total Debt | $444,475,000 | $473,565,000 | $415,667,000 | $419,877,000 |
| Long Term Debt And Capital Lease Obligation | $425,003,000 | $414,687,000 | $398,607,000 | $406,756,000 |
| Long Term Debt | $310,036,000 | $308,266,000 | $285,035,000 | $283,232,000 |
| Current Debt And Capital Lease Obligation | $19,472,000 | $58,878,000 | $17,060,000 | $13,121,000 |
| Current Debt | - | $40,670,000 | - | - |
| Other Current Borrowings | - | $40,670,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $725,942,000 | $704,560,000 | $639,026,000 | $612,838,000 |
| Total Non Current Liabilities Net Minority Interest | $483,218,000 | $457,511,000 | $443,768,000 | $447,548,000 |
| Other Non Current Liabilities | $49,741,000 | $32,369,000 | $31,830,000 | $23,918,000 |
| Non Current Deferred Liabilities | $8,474,000 | $10,455,000 | $13,331,000 | $16,874,000 |
| Current Liabilities | $242,724,000 | $247,049,000 | $195,258,000 | $165,290,000 |
| Other Current Liabilities | $75,237,000 | $49,312,000 | $28,462,000 | $29,325,000 |
| Current Deferred Liabilities | $9,527,000 | $11,831,000 | $43,994,000 | $18,837,000 |
| Payables And Accrued Expenses | $68,079,000 | $62,900,000 | $62,312,000 | $65,325,000 |
| Payables | $47,067,000 | $44,730,000 | $49,586,000 | $55,730,000 |
| Accounts Payable | $47,067,000 | $44,730,000 | $49,586,000 | $55,730,000 |
| Equity | ||||
| Common Stock Equity | $155,170,000 | $263,098,000 | $313,632,000 | $439,947,000 |
| Total Equity Gross Minority Interest | $155,170,000 | $263,098,000 | $313,632,000 | $439,947,000 |
| Stockholders Equity | $155,170,000 | $263,098,000 | $313,632,000 | $439,947,000 |
| Gains Losses Not Affecting Retained Earnings | $5,593,000 | $-1,947,000 | $1,369,000 | $-1,817,000 |
| Other Equity Adjustments | $5,593,000 | $-1,947,000 | $1,369,000 | $-1,817,000 |
| Retained Earnings | $-1,252,535,000 | $-1,047,825,000 | $-951,800,000 | $-729,189,000 |
| Long Term Equity Investment | $60,351,000 | $74,545,000 | $0 | - |
| Other | ||||
| Ordinary Shares Number | $68,291,000 | $66,264,000 | $65,552,000 | $64,513,000 |
| Share Issued | $68,291,000 | $66,264,000 | $65,552,000 | $64,513,000 |
| Tangible Book Value | $143,450,000 | $262,173,000 | $310,856,000 | $435,320,000 |
| Invested Capital | $465,206,000 | $612,034,000 | $598,667,000 | $723,179,000 |
| Working Capital | $375,419,000 | $477,442,000 | $552,731,000 | $684,686,000 |
| Capital Lease Obligations | $134,439,000 | $124,629,000 | $130,632,000 | $136,645,000 |
| Total Capitalization | $465,206,000 | $571,364,000 | $598,667,000 | $723,179,000 |
| Additional Paid In Capital | $1,402,044,000 | $1,312,804,000 | $1,263,997,000 | $1,170,888,000 |
| Capital Stock | $68,000 | $66,000 | $66,000 | $65,000 |
| Common Stock | $68,000 | $66,000 | $66,000 | $65,000 |
| Non Current Deferred Revenue | $8,474,000 | $10,455,000 | $13,331,000 | $16,874,000 |
| Long Term Capital Lease Obligation | $114,967,000 | $106,421,000 | $113,572,000 | $123,524,000 |
| Current Deferred Revenue | $9,527,000 | $11,831,000 | $43,994,000 | $18,837,000 |
| Current Capital Lease Obligation | $19,472,000 | $18,208,000 | $17,060,000 | $13,121,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $70,409,000 | $64,128,000 | $43,430,000 | $38,682,000 |
| Current Accrued Expenses | $21,012,000 | $18,170,000 | $12,726,000 | $9,595,000 |
| Investments And Advances | $60,351,000 | $74,545,000 | $0 | - |
| Net PPE | $179,752,000 | $163,456,000 | $164,333,000 | $179,178,000 |
| Accumulated Depreciation | $-73,047,000 | $-62,828,000 | $-52,794,000 | $-56,175,000 |
| Gross PPE | $252,799,000 | $226,284,000 | $217,127,000 | $235,353,000 |
| Leases | $136,298,000 | $122,412,000 | $125,356,000 | $146,454,000 |
| Other Properties | $99,273,000 | $82,248,000 | $69,589,000 | $62,797,000 |
| Machinery Furniture Equipment | $17,228,000 | $21,624,000 | $22,182,000 | $26,102,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $73,194,000 | $83,493,000 | $71,128,000 | $53,339,000 |
| Work In Process | $23,805,000 | $33,517,000 | $44,026,000 | $18,571,000 |
| Raw Materials | $31,770,000 | $32,602,000 | $42,783,000 | $39,207,000 |
| Other Short Term Investments | $202,032,000 | $369,095,000 | $409,044,000 | $444,384,000 |
Fetched: 2026-07-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-108,257,000 | $4,994,000 | $-128,110,000 | $16,367,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-9,721,000 | $24,225,000 | $-31,810,000 | $50,464,000 |
| Cash Flow From Continuing Operating Activities | $-9,721,000 | $24,225,000 | $-31,810,000 | $50,464,000 |
| Operating Gains Losses | $14,194,000 | $3,321,000 | - | $-147,000 |
| Investing Activities | ||||
| Capital Expenditure | $-98,536,000 | $-19,231,000 | $-96,300,000 | $-34,097,000 |
| Investing Cash Flow | $72,876,000 | $-23,482,000 | $-85,740,000 | $33,168,000 |
| Cash Flow From Continuing Investing Activities | $72,876,000 | $-23,482,000 | $-85,740,000 | $33,168,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-43,367,000 | $8,367,000 | $4,113,000 | $16,877,000 |
| Cash Flow From Continuing Financing Activities | $-43,367,000 | $8,367,000 | $4,113,000 | $16,877,000 |
| Net Common Stock Issuance | $0 | $-30,000,000 | $0 | $0 |
| Net Other Financing Charges | - | $-15,630,000 | $-71,000 | $-592,000 |
| Other | ||||
| Repayment Of Debt | $-40,760,000 | $-246,123,000 | $0 | $0 |
| Issuance Of Debt | $0 | $306,850,000 | $0 | $0 |
| Interest Paid Supplemental Data | $5,049,000 | $3,076,000 | $7,565,000 | $4,313,000 |
| Income Tax Paid Supplemental Data | $5,056,000 | $3,098,000 | $1,923,000 | $411,000 |
| End Cash Position | $90,634,000 | $69,234,000 | $58,868,000 | $172,517,000 |
| Beginning Cash Position | $69,234,000 | $58,868,000 | $172,517,000 | $71,181,000 |
| Effect Of Exchange Rate Changes | $1,612,000 | $1,256,000 | $-212,000 | $827,000 |
| Changes In Cash | $19,788,000 | $9,110,000 | $-113,437,000 | $100,509,000 |
| Proceeds From Stock Option Exercised | $-2,607,000 | $-6,730,000 | $4,184,000 | $17,469,000 |
| Net Issuance Payments Of Debt | $-40,760,000 | $60,727,000 | $0 | $0 |
| Net Long Term Debt Issuance | $-40,760,000 | $60,727,000 | $0 | $0 |
| Long Term Debt Payments | $-40,760,000 | $-246,123,000 | $0 | $0 |
| Long Term Debt Issuance | $0 | $306,850,000 | $0 | $0 |
| Net Investment Purchase And Sale | $171,412,000 | $-4,251,000 | $10,560,000 | $92,985,000 |
| Sale Of Investment | $257,072,000 | $306,464,000 | $546,218,000 | $569,492,000 |
| Purchase Of Investment | $-85,660,000 | $-310,715,000 | $-535,658,000 | $-476,507,000 |
| Net Intangibles Purchase And Sale | $-78,588,000 | $0 | $-69,496,000 | $-8,855,000 |
| Purchase Of Intangibles | $-78,588,000 | $0 | $-69,496,000 | $-8,855,000 |
| Net PPE Purchase And Sale | $-19,948,000 | $-19,231,000 | $-26,804,000 | $-34,097,000 |
| Purchase Of PPE | $-19,948,000 | $-19,231,000 | $-26,804,000 | $-34,097,000 |
| Change In Working Capital | $-23,039,000 | $-11,781,000 | $-17,685,000 | $-4,649,000 |
| Change In Other Working Capital | $1,207,000 | $-13,877,000 | $26,692,000 | $-4,511,000 |
| Change In Other Current Liabilities | $22,163,000 | $18,595,000 | $12,052,000 | $27,377,000 |
| Change In Other Current Assets | $-6,888,000 | $893,000 | $-3,187,000 | $-1,207,000 |
| Change In Payables And Accrued Expense | $1,563,000 | $3,158,000 | $-2,327,000 | $24,032,000 |
| Change In Accrued Expense | $-664,000 | $5,550,000 | $2,537,000 | $-461,000 |
| Change In Payable | $2,227,000 | $-2,392,000 | $-4,864,000 | $24,493,000 |
| Change In Account Payable | $2,227,000 | $-2,392,000 | $-4,864,000 | $24,493,000 |
| Change In Prepaid Assets | $-9,088,000 | $-5,565,000 | $-9,139,000 | $-58,000 |
| Change In Inventory | $24,816,000 | $5,810,000 | $-46,053,000 | $-42,452,000 |
| Change In Receivables | $-56,812,000 | $-20,795,000 | $4,277,000 | $-7,830,000 |
| Changes In Account Receivables | $-56,812,000 | $-20,795,000 | $4,277,000 | $-7,830,000 |
| Other Non Cash Items | $88,137,000 | $3,062,000 | $95,568,000 | $41,490,000 |
| Stock Based Compensation | $92,381,000 | $101,383,000 | $88,076,000 | $84,918,000 |
| Provisionand Write Offof Assets | $9,478,000 | $9,979,000 | $5,540,000 | $4,782,000 |
| Amortization Of Securities | $-3,828,000 | $-2,321,000 | $3,587,000 | $4,187,000 |
| Depreciation Amortization Depletion | $17,666,000 | $16,607,000 | $15,715,000 | $14,330,000 |
| Depreciation And Amortization | $17,666,000 | $16,607,000 | $15,715,000 | $14,330,000 |
| Amortization Cash Flow | $2,500,000 | $1,900,000 | $1,900,000 | $2,000,000 |
| Amortization Of Intangibles | $2,500,000 | $1,900,000 | $1,900,000 | $2,000,000 |
| Depreciation | $15,100,000 | $14,700,000 | $13,800,000 | $12,300,000 |
| Earnings Losses From Equity Investments | $14,194,000 | $2,053,000 | $0 | $0 |
| Net Income From Continuing Operations | $-204,710,000 | $-96,025,000 | $-222,611,000 | $-94,594,000 |
| Net Business Purchase And Sale | - | $0 | $-69,496,000 | $-25,720,000 |
| Purchase Of Business | - | $0 | $-69,496,000 | $-25,720,000 |
| Asset Impairment Charge | - | - | - | $7,567,000 |
| Deferred Tax | - | - | - | $0 |
| Deferred Income Tax | - | - | - | $0 |
| Gain Loss On Investment Securities | - | - | - | $-147,000 |
Fetched: 2026-07-18